Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EBIT Margin

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EBIT Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Margin(%) 17.4411.017.446.856.15

What is the latest EBIT Margin ratio of VENUS REMEDIES ?

The latest EBIT Margin ratio of VENUS REMEDIES is 17.44 based on Mar2026 Consolidated results.
Year EBIT Margin
Mar202617.44
Mar202511.01
Mar20247.44
Mar20236.85
Mar20226.15

How is EBIT Margin of VENUS REMEDIES Trending?

Years EBIT Margin % Change
Mar2026 17.44
58.40
Mar2025 11.01
47.98
Mar2024 7.44
8.61
Mar2023 6.85
11.38
Mar2022 6.15 -

Other Financial Ratios of VENUS REMEDIES


Compare EBIT Margin ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹2,185.1 Cr 1.4% 2.1% 275.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,478.0 Cr -0.2% -3.2% 12.7% Stock Analytics
DIVIS LABORATORIES ₹253,031.0 Cr 2% 5.3% 57.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,216.0 Cr -2.4% -3.1% 36.4% Stock Analytics
CIPLA ₹112,205.0 Cr 0.6% -2.2% -9.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,040.0 Cr 0.9% 4% -7.6% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

1.4%

2.1%

275.6%

SENSEX

-2.8%

-6.1%

-11.9%


You may also like the below Video Courses